Fibromyalgia Syndrome on Patients With Chronic Migraine
CompletedNot applicableNCT05381012
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study to evaluate the effects of fibromyalgia syndrome accompanying women with chronic migraine on pain, quality of life, sleep, anxiety and depression, central sensitization and functionality.
Study details
- Official title
- The Effect of Fibromyalgia Syndrome on Female Patients With Chronic Migraine
- Conditions
- Interventions
- Other: Allodynia, quality of life, sleep, anxiety and depression, disability, and central sensitization
- Other: Fibromyalgia syndrome
- Sponsor
- Istanbul University - Cerrahpasa
- Start date
- 2022-05-01
- Primary completion
- 2022-11-01
- Sex
- Female
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: For patients with chronic migraine: * Being diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3) * Being literate For patients with fibromyalgia syndrome: * Diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3) * Being literate * Diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology criteria Exclusion Criteria: * Having another pathology that can explain their pain in the head and face region other than chronic migraine (such as sinusitis, tension-type headache, trigeminal neuralgia, drug overuse headache) * Psychiatric disease or using psychiatric drugs * History of serious head trauma or neurosurgical intervention * History of infectious, chronic inflammatory disease, malignancy * Pregnant and breastfeeding women * History of additional neurological disease other than migraine * Uncooperative * Having congestive heart failure, chronic kidney failure, chronic liver disease, lung disease, uncontrolled diabetes, peripheral vascular disease * Diagnosed with hypothyroidism or hyperthyroidism
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05381012